SEC Filings TLDR

Situational Awareness LP, along with its associates, has acquired a 5.8% stake in Core Scientific, Inc., a company listed on the stock exchange. The acquisition was made for investment purposes, with the reporting persons believing that the common stock was undervalued and represented an attractive investment opportuni...

Coastlands Capital LP, along with its affiliates Coastlands Capital Partners LP, Coastlands Capital GP LLC, Coastlands Capital LLC, and Matthew D. Perry, have filed a Schedule 13D with the SEC regarding their holdings in X4 Pharmaceuticals, Inc. The filing discloses that the Reporting Persons collectively beneficially ...

Michael Otworth, the Executive Chairman and a Class III director of Innventure, Inc., filed a Schedule 13D with the SEC on April 24, 2025. The filing discloses that Otworth beneficially owns 2,942,902 shares of Innventure's common stock, representing approximately 5.5% of the outstanding shares. Otworth acquired these ...

BridgeBio Pharma LLC and BridgeBio Pharma, Inc. have filed a Schedule 13D with the SEC, disclosing their acquisition of a 17.5% stake in BridgeBio Oncology Therapeutics, Inc. The acquisition was completed on August 11, 2025, following a business combination agreement. The Reporting Persons, BridgeBio Pharma LLC and Bri...

The Schedule 13D filing by Soho House & Co Inc. discloses significant ownership and control details by key individuals and entities, including Nick Jones, Richard Caring, and Ronald Burkle, along with various Yucaipa funds. The filing outlines their collective beneficial ownership of Class A and Class B Common Stock, r...

The Schedule 13D filing by TSSP Sub-Fund HoldCo, LLC and Alan Waxman relates to their investment in Plymouth Industrial REIT, Inc. The filing discloses the acquisition of Series C Cumulative Perpetual Preferred Units and warrants to purchase common partnership units (OP Units) in the company's subsidiary, Plymouth Indu...

On August 7, 2025, Kingsway Fund - Frontier Consumer Franchises (KFCF), FC02 Digital Ltd, Kingsway Frontier Consumer Opportunities (FCO4) Growth Fund IV Ltd, SP12 Digital Ltd, SP13 Digital Ltd, SP14 Digital Ltd, and SP15 Digital Ltd, collectively referred to as the 'Funds', along with Kingsway Capital Partners Limited ...

GSK plc, a global biopharma company, filed a Schedule 13D with the SEC regarding its ownership of common shares in CureVac N.V., a Netherlands-based biopharmaceutical company. The filing discloses that GSK, through its wholly-owned subsidiary Glaxo Group Limited (GGL), owns 16,591,937 common shares, representing approx...

Robert Gregory Kidd and Goldeneye 1995 LLC have filed a Schedule 13D with the SEC, disclosing their ownership of 357,815,000 shares of common stock in Know Labs, Inc., representing approximately 93.1% of the outstanding shares. The filing details the acquisition of these shares through a private placement on August 6, ...

Bain Capital Life Sciences Fund, L.P., Bain Capital Life Sciences Fund II, L.P., BCIP Life Sciences Associates, LP, BCLS II Investco, LP, and BCLS I Investco, LP (collectively, the "Reporting Persons") have filed a Schedule 13D to report their acquisition of a significant stake in X4 Pharmaceuticals, Inc. The Reporting...

HX Entertainment Ltd., a Malta-based investment and entertainment services company controlled by Alexandre Dreyfus, has acquired a 10.9% stake in Processa Pharmaceuticals, Inc. The acquisition involves 5,467,181 shares of Common Stock, purchased at approximately $0.2275 per share, totaling around $1,243,784. The funds ...

Public Sector Pension Investment Board (PSP) and its subsidiary PSP Investments Credit USA LLC (PSP USA) have filed a Schedule 13D with the SEC regarding their ownership of Class A Common Stock in GoHealth, Inc. The filing discloses that PSP and PSP USA collectively own approximately 10.5% of GoHealth's Class A Common ...

Redwood Capital Management, LLC, along with its affiliates Redwood Capital Management Holdings, LP, Double Twins K, LLC, and Ruben Kliksberg, collectively known as the Reporting Persons, have filed a Schedule 13D indicating a 5.8% ownership stake in GoHealth, Inc.'s Class A Common Stock. The shares were acquired as par...

GSK plc filed a Schedule 13D with the SEC regarding its ownership of common shares in CureVac N.V. The filing indicates that GSK, through its wholly-owned subsidiary Glaxo Group Limited (GGL), owns 16,591,937 common shares, representing 74% of the outstanding shares. GSK acquired these shares for investment purposes an...

Blue Torch Capital LP and Kevin Genda filed a Schedule 13D with the SEC regarding their ownership of Class A Common Stock in GoHealth, Inc. The filing discloses that Blue Torch Capital LP, a Delaware limited partnership, and Kevin Genda, the Managing Member of KPG BTC Management LLC, collectively own 1,445,181 shares, ...

Loews Corporation filed a Schedule 13D with the SEC on August 12, 2025, disclosing its ownership of 31,900,000 shares of Hanesbrands Inc.'s Common Stock, representing 9.0% of the outstanding shares. The filing indicates that Loews Corporation acquired these shares for investment purposes and used $49,304,124 of its cas...

Loews Corporation filed a Schedule 13D with the SEC on August 12, 2025, disclosing its ownership of 31,900,000 shares of Hanesbrands Inc.'s Common Stock, representing 9.0% of the outstanding shares. The filing indicates that Loews Corporation acquired these shares for investment purposes and used $49,304,124 of its cas...

SiVantage Inc. has filed a Schedule 13D with the SEC, disclosing its acquisition of a significant stake in Tenon Medical, Inc. The filing reveals that SiVantage Inc. now beneficially owns approximately 12.5% of Tenon Medical's common stock, totaling 986,528 shares. This acquisition is part of a broader transaction invo...

Doma Perpetual Capital Management LLC, along with related entities and Pedro Escudero, filed a Schedule 13D with the SEC regarding their ownership of Common Shares in Pacira BioSciences, Inc. The filing indicates that Doma, on behalf of Doma Master Fund and The John Templeton Foundation, purchased a total of 2,699,618 ...

Two Seas Capital LP, Two Seas Capital GP LLC, and Sina Toussi (collectively, the 'Reporting Persons') filed a Schedule 13D with the SEC regarding their holdings in Core Scientific, Inc. The Reporting Persons collectively own approximately 6.3% of Core Scientific's common stock, including warrants and options. The filin...

Bit Digital, Inc., a Cayman Islands exempted company, has acquired approximately 74.3% of the issued and outstanding Ordinary Shares of WhiteFiber, Inc. through a Contribution Agreement. This agreement involved the transfer of 100% of the capital shares of WhiteFiber AI, Inc. and its wholly-owned subsidiaries, WhiteFib...

David Nate Breslauer, Chief Technology Officer, Chief Product Officer, and a director of Bolt Projects Holdings, Inc., filed a Schedule 13D disclosing his beneficial ownership of 115,214 shares of the company's common stock, representing approximately 5.4% of the outstanding shares. The filing details the acquisition o...

Jasper Lake Ventures One LLC and Noah Kolatch have filed a Schedule 13D indicating their investment in Bioceres Crop Solutions Corp. As of August 1, 2025, they hold or have the right to acquire 7,382,919 Ordinary Shares, representing approximately 10.6% of the outstanding shares. The shares are held through a Secured G...

HNI Corporation filed a Schedule 13D with the SEC regarding its acquisition of Steelcase Inc. The filing outlines the details of the merger agreement, which involves HNI acquiring control of Steelcase through two mergers. The first merger will merge a subsidiary of HNI with Steelcase, and the second will merge Steelcas...

TPG GP A, LLC, along with James G. Coulter and Jon Winkelried, filed a Schedule 13D with the SEC regarding their holdings in AG Mortgage Investment Trust, Inc. The filing discloses that the reporting persons collectively own approximately 7.3% of the company's common stock, totaling 2,315,966 shares. The shares are hel...